Use of Intrathecal Baclofen for Treatment of Severe Spasticity in Selected Patients With Motor Neuron Disease (original) (raw)
Managing Spasticity in People With Multiple Sclerosis: A Goal-Oriented Approach to Intrathecal Baclofen Therapy
davina Richardson
International Journal of MS Care, 2001
View PDFchevron_right
Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy
Charles Law
Archives of Physical Medicine and Rehabilitation, 2001
View PDFchevron_right
Chronic intrathecal baclofen administration for control of severe spasticity
John Ulatowski
Journal of Neurosurgery, 1990
View PDFchevron_right
Intrathecal Baclofen Management of Poststroke Spastic Hypertonia: Implications for Function and Quality of Life
Cindy Ivanhoe
Archives of Physical Medicine and Rehabilitation, 2006
View PDFchevron_right
A Randomized, Double-Blinded, Crossover Pilot Study Assessing the Effect of Nabilone on Spasticity in Persons With Spinal Cord Injury
Karen Ethans
Archives of Physical Medicine and Rehabilitation, 2010
View PDFchevron_right
Clinical Features of Spasticity and Principles of Treatment
Alexander Dromerick
Clinical Evaluation and Management of Spasticity, 2001
View PDFchevron_right
Spasticity Treatment During COVID-19 Pandemic: Clinical Recommendations
Nicola Smania
Frontiers in Neurology, 2020
View PDFchevron_right
Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study
Bengt Linderoth
Journal of Neurology, Neurosurgery & Psychiatry, 1989
View PDFchevron_right
Spasticity and Upper Motor Neuron Dysfunction
Arthur Sherwood, Barry McKay
Wiley Encyclopedia of Biomedical Engineering, 2006
View PDFchevron_right
Intrathecal Baclofen for the Treatment of Spasticity of Cerebral Origin
jeanette josefina peña
Journal for Specialists in Pediatric Nursing, 2003
View PDFchevron_right
Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome
Giampietro Schiavo
Toxicon, 2013
View PDFchevron_right
The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen
R. Stien, Hild Nordal
Acta Neurologica Scandinavica, 1987
View PDFchevron_right
Continuous intrathecal baclofen delivery in severely disabling spasticity
M. Güney Şenol, Selim Akarsu, Emre Zorlu
2018
View PDFchevron_right
Comparison of the effect of baclofen and transcutaneous electrical nerve stimulation for the treatment of spasticity in multiple sclerosis
Mohsen Janghorbani
Neurological Research, 2013
View PDFchevron_right
Intrathecal baclofen therapy in patients with severe spasticity
Mary Elizabeth Nelson
Acta Neurochirurgica Supplements
View PDFchevron_right
Contemporary Pharmacologic Treatments for Spasticity of the Upper Limb After Stroke: A Systematic Review
Edward Armstrong
Clinical Therapeutics, 2010
View PDFchevron_right
Validity, reliability, and clinical importance of change in a 0—10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial
John Farrar
2008
View PDFchevron_right
Non-pharmacological interventions for spasticity in adults: An overview of systematic reviews
Bhasker Amatya
Annals of physical and rehabilitation medicine, 2018
View PDFchevron_right
Non pharmacological interventions for spasticity in multiple sclerosis
Bhasker Amatya
Protocols, 2012
View PDFchevron_right
Intrathecal Baclofen for Spastic Hypertonia From Stroke Editorial Comment
Mark Hadley, Jay Meythaler, Robert Brunner
Stroke, 2001
View PDFchevron_right
Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury
Jay Meythaler
Archives of Physical Medicine and Rehabilitation, 1996
View PDFchevron_right
Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: Efficacy and factors associated with pain relief
Erik Pioro
Muscle & Nerve, 2008
View PDFchevron_right
Long-term modification of spasticity 61
Anthony Ward
View PDFchevron_right
Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin
Leland Albright
Journal of Neurosurgery, 2003
View PDFchevron_right
Intrathecal Baclofen Dosage for Long-Term Treatment of Patients With Spasticity Due to Traumatic Spinal Cord Injuries or Multiple Sclerosis
Bengt Skoog
Annals of Rehabilitation Medicine
View PDFchevron_right
Spasticity and its management
Barry Rawicki
Current Therapeutics, 2001
View PDFchevron_right
Intrathecal baclofen administration for control of severe spinal spasticity: Functional improvement and long-term follow-up
Pierre Denys
Archives of Physical Medicine and Rehabilitation, 1996
View PDFchevron_right
Drug treatments for spasticity
M. Rousseaux
Annals of Physical and Rehabilitation Medicine, 2009
View PDFchevron_right